Latest | Forecast | |
---|---|---|
Div Yield | n/a | n/a |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | Forecast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Price / Revenue | n/a | n/a |
Price / Book value | n/a |
Latest | Forecast | |
---|---|---|
Revenue | 23.2% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-12-31 | 0.26 | -0.72 | -0.48p | -21.4 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 0.52 | -0.50 | -0.29p | -20.7 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 0.54 | -0.51 | -0.28p | -6.5 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 0.61 | -0.62 | -0.34p | -13.8 | 0.0 | n/a | n/a | 0.0% |
2024-12-31 | 0.75 | -0.33 | -0.15p | -9.3 | 0.0 | n/a | n/a | 0.0% |
Change of Name | 27-May-25 07:02 |
---|---|
Result of AGM | 22-May-25 14:23 |
Application: FDA Breakthrough Therapy Designation | 02-May-25 22:56 |
Notice of AGM | 29-Apr-25 23:06 |
Publication of Annual Report | 25-Apr-25 22:56 |